FindTrial
Sign In

Study to look for cardiovascular manifestations of COVID

To study cardiovascular involvement in COVID 19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029981
Enrollment
100
Registered
2020-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B338- Other specified viral diseases

Interventions

None listed

Sponsors

Rohit Walia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with COVID 19 disease confirmed by RTPCR Age greater than 18 years

Exclusion criteria

Exclusion criteria: Not giving informed consent

Design outcomes

Primary

MeasureTime frame
Incidence of acute myocardial events in COVID-19 population at baseline and during hospital stayTimepoint: Incidence of acute myocardial events in COVID-19 population at baseline and during hospital stay—

Secondary

MeasureTime frame
Cardiovascular outcomes : myocardial infarction or stenosis, stroke, pulmonary embolism, deep vein thrombosis, ventricular dysfunction, conduction disorders and sudden deathTimepoint: 14 days till hospitalisation;New-onset cardiac arrhythmiaTimepoint: 14 days since hospitalisation;To evaluate the reversibility or progression of cardiac involvement at 2 months of follow up vs. at discharge timeTimepoint: 2 months—

Countries

India

Contacts

Public ContactRohit Walia

All India Institute of Medical Science Rishikesh

rwalia7731@yahoo.in8800492549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026